Company Overview of iCeutica Inc.
iCeutica Inc. engages in developing and commercializing medicines in Pennsylvania. It offers SoluMatrix, a dry milling technology that grinds the drug particles into a superfine powder and protects those submicron particles from subsequent agglomeration. The company offers its pipeline of product candidates for pain and inflammation indications; oncology, including lung cancer and leukemia; respiratory diseases, such as asthma, COPD, and allergic diseases; and migraine. It offers its products through partners, as well as through licensing. The company was founded in 2003 and is based in Philadelphia, Pennsylvania. It has a research and development office in King of Prussia, Pennsylvania; and...
One Kew Place
150 Rouse Boulevard
Navy Yard Corporate Center
Philadelphia, PA 19112
Founded in 2003
Key Executives for iCeutica Inc.
Chief Executive Officer and President
Vice President of Research and Development
Vice President of Clinical Development and Regulatory Affairs
Vice President of Process Development and Engineering
Compensation as of Fiscal Year 2016.
iCeutica Inc. Key Developments
iCeutica Inc. Presents at BIO-Europe Spring 2015, Mar-10-2015 05:30 PM
Jan 29 15
iCeutica Inc. Presents at BIO-Europe Spring 2015, Mar-10-2015 05:30 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
iCeutica Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 08:00 AM
Dec 18 14
iCeutica Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 08:00 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
iCeutica Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014
Sep 10 14
iCeutica Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries